MT-2 vial

MW

1,024.2 g/mol

Purity

>99%

Pigmentation

MT-2

Melanotan II — Cyclic Alpha-MSH Analog

Cyclic synthetic analog of alpha-melanocyte-stimulating hormone

$75

Per vial · Research use only · COA available

Compound Profile

AppearanceLyophilized white powder
Molecular Weight1,024.2 g/mol
Amino Acids7 (cyclic)
Dosage10 mg
Volume3 mL
SolubilityBacteriostatic or sterile water
Purity≥98% (HPLC-UV-MS verified)
Storage−20°C long-term · 4°C short-term · Protect from light

Amino Acid Sequence

Ac-Nle-cyclo[Asp-His-DPhe-Arg-Trp-Lys]-NH2

Third-Party VerifiedCOA AvailableLyophilizedResearch Grade≥98% Purity

COA, sterility, endotoxin, and heavy metal test results available upon request.

For Research Use Only. This product is not for human consumption, clinical use, or veterinary use. Must be 21+ to purchase. Not evaluated or approved by the FDA for any therapeutic use. Introduction into humans or animals is strictly prohibited by law.

Overview

About MT-2

Melanotan II (MT-2) is a cyclic synthetic analog of alpha-melanocyte-stimulating hormone. Unlike the linear, MC1R-selective MT-1, MT-2's cyclic structure gives it broader, nonselective activity across multiple melanocortin receptor subtypes, making it a research reference compound for both pigmentation pathways and central melanocortin signaling.

Mechanism of Action

How It Works

MT-2 acts as a nonselective agonist across MC1R, MC3R, and MC4R. MC1R activation on melanocytes drives the same cAMP-mediated tyrosinase upregulation and eumelanin synthesis studied with MT-1. Its additional activity at central MC4R receptors has made it a key structural reference in research on appetite regulation and sexual arousal pathways — MT-2's cyclic core is the structural basis from which the more MC4R-selective compound bremelanotide (PT-141) was later derived.

Scientific Literature

Research Highlights

01

Nonselective melanocortin receptor agonism — MC1R, MC3R, and MC4R activity studied

02

Pigmentation research via MC1R-mediated tyrosinase and eumelanin pathways

03

Central MC4R activity — structural precursor referenced in bremelanotide (PT-141) research

04

Studied appetite-suppression signaling through hypothalamic melanocortin pathways

05

Studied activity in sexual arousal and libido research models via central MC4R

06

Broader receptor profile used as a comparative reference against selective analogs like MT-1

07

Cyclic peptide structure studied for receptor-binding stability

Research Disclaimer: All research highlights are derived from published preclinical, in vitro, and animal studies. Results observed in laboratory models may not translate to human outcomes. Genfinite makes no claims regarding therapeutic efficacy. All products are sold strictly for scientific research purposes only.

Handling

Storage & Reconstitution

01

Dry Storage

Store lyophilized powder at −20°C, away from light and moisture. Do not open until ready to use. Shelf life is significantly extended by proper dry storage.

02

Reconstitution

Reconstitute using Bacteriostatic or sterile water. Add solvent slowly to the side of the vial and allow to dissolve gently. Do not shake vigorously.

03

Post-Reconstitution

Store reconstituted solution refrigerated at 4°C. Use within your laboratory's established timeframe. Do not refreeze after reconstitution.